Concepedia

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

Ian Judson, John Radford, Martin Harris, Jean‐Yves Blay, Q. van Hoesel, Axel Le Cesne, A.T. van Oosterom, M. Clemons, Claus Kamby, C. Hermans,

European Journal of Cancer · 2001 · 391 citations · 14 references

DOI

Concepts

References

14

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

New England Journal of Medicine · 1993 · 5K citations · Full text

, , +15

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis et al. · Journal of Clinical Oncology · 1999 · 570 citations

, , +16

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Armando Santoro, T Türsz, Henning T. Mouridsen et al. · Journal of Clinical Oncology · 1995 · 530 citations

, , +14

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

J H Edmonson, Louise Ryan, Ronald H. Blum et al. · Journal of Clinical Oncology · 1993 · 518 citations

, , +13

Doxorubicin in sterically stabilized liposomes

Danilo D. Lasiç · Nature · 1996 · 309 citations

, , +10